BioSpace News Archive

Drug Development

First Clinical Data for X4P-001-RD Demonstrated Promising Activity in Patients With WHIM Syndrome, a Primary Immunodeficiency Disease

The preliminary results from the study demonstrated promising activity with dose-dependent increases in neutrophil and lymphocyte counts in patients with WHIM syndrome.

December 11, 2017

·

6 min read

MOLOGEN AG: Poster Presentations on Lefitolimod and EnanDIM at ESMO IO 2017

Based on the findings of MOLOGEN’s phase II IMPACT study, IMPALA aims to prove that a switch maintenance therapy with an active immunotherapy leads to an increased overall survival of patients who have achieved a response during their first line treatment of metastatic colorectal cancer.

December 11, 2017

·

7 min read

Drug Development

Samumed Doses First Patient in Phase I Trial of SM08502 for Treatment of Advanced Solid Tumors

This Phase 1, open-label, multi-center, dose-escalation study will evaluate the safety, tolerability and pharmacokinetics (PK) of orally administered SM08502 in subjects with advanced solid tumors.

December 11, 2017

·

1 min read

Biotech Beach

Vital Therapies Added to NASDAQ Biotechnology Index

This will become effective prior to the open of U.S. markets Monday, December 18, 2017.

December 11, 2017

·

1 min read

Drug Development

Caelum Biosciences Announces Positive Phase Ia/Ib Data Demonstrating CAEL-101 (mAb 11-1F4) Improves Organ Function in AL Amyloidosis

Caelum in-licensed CAEL-101 from Columbia and recently completed a Phase 1a/1b clinical trial at Columbia for the treatment of AL amyloidosis.

December 11, 2017

·

7 min read

Business

Inovio Pharmaceuticals Promotes Dr. Laurent Humeau to Senior Vice President, Research & Development

New strategic position will guide product discovery anDr. Humeau will serve an integral role in advancing Inovio’s portfolio of ASPIRE immunotherapies and vaccinesd scientific collaborations.

December 11, 2017

·

4 min read

Business

Bay Area’s Graybug Vision Adds Four Top Execs to the Roster

The company announced the addition of four key members to its leadership team as it continues to advance its novel ocular treatments through clinical development and evolve into a commercial biotech company.

December 11, 2017

·

5 min read

Business

MilliporeSigma Signs Distribution Agreement With Avanti Polar Lipids

Under the terms of the agreement, MilliporeSigma will employ its sales, marketing and e-commerce expertise to distribute Avanti Polar Lipid’s research lipid portfolio.

December 11, 2017

·

3 min read

Drug Development

Anthera Pharmaceuticals Announces Positive Outcome of Interim Futility Analysis in the Phase III RESULT Clinical Study of Sollpura

The study will proceed, as planned, with topline data expected in Q1 2018.

December 11, 2017

·

2 min read

Policy

PharmaCyte Biotech Meets With Oncology Advisory Board

PharmaCyte Biotech announced that it recently met with its Oncology Advisory Board, which was formed to assist in optimizing and finalizing the clinical protocol and other clinical trial-related matters.

December 11, 2017

·

4 min read